ATA49889A - Pharmazeutische verwendung von agmatin - Google Patents

Pharmazeutische verwendung von agmatin

Info

Publication number
ATA49889A
ATA49889A AT49889A AT49889A ATA49889A AT A49889 A ATA49889 A AT A49889A AT 49889 A AT49889 A AT 49889A AT 49889 A AT49889 A AT 49889A AT A49889 A ATA49889 A AT A49889A
Authority
AT
Austria
Prior art keywords
agmatine
pharmaceutical use
pharmaceutical
Prior art date
Application number
AT49889A
Other languages
English (en)
Other versions
AT393079B (de
Original Assignee
Lubec Gert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lubec Gert filed Critical Lubec Gert
Priority to AT49889A priority Critical patent/AT393079B/de
Priority to AT89890116T priority patent/ATE83658T1/de
Priority to EP89890116A priority patent/EP0370994B1/de
Priority to DE8989890116T priority patent/DE58903113D1/de
Priority to JP1132505A priority patent/JPH02145514A/ja
Priority to US07/367,474 priority patent/US5077313A/en
Publication of ATA49889A publication Critical patent/ATA49889A/de
Application granted granted Critical
Publication of AT393079B publication Critical patent/AT393079B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT49889A 1988-11-25 1989-03-06 Pharmazeutische verwendung von agmatin AT393079B (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AT49889A AT393079B (de) 1989-03-06 1989-03-06 Pharmazeutische verwendung von agmatin
AT89890116T ATE83658T1 (de) 1988-11-25 1989-04-20 Behandlung von durch glucose ausgeloester quervernetzung von collagen bei diabetes mellitus-patienten durch arginin, spermidin, kreatin oder agmatin.
EP89890116A EP0370994B1 (de) 1988-11-25 1989-04-20 Behandlung von durch Glucose ausgelöster Quervernetzung von Collagen bei Diabetes mellitus-Patienten durch Arginin, Spermidin, Kreatin oder Agmatin
DE8989890116T DE58903113D1 (de) 1988-11-25 1989-04-20 Behandlung von durch glucose ausgeloester quervernetzung von collagen bei diabetes mellitus-patienten durch arginin, spermidin, kreatin oder agmatin.
JP1132505A JPH02145514A (ja) 1988-11-25 1989-05-25 糖尿病患者のグルコーゼ仲介コラーゲンクロス―リンクをアルギニン、スペルミジン、クレアチン又はアグマチンによる治療法
US07/367,474 US5077313A (en) 1988-11-25 1989-06-16 Process for inhibiting pathological collagen cross-linking in diabetes patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT49889A AT393079B (de) 1989-03-06 1989-03-06 Pharmazeutische verwendung von agmatin

Publications (2)

Publication Number Publication Date
ATA49889A true ATA49889A (de) 1991-01-15
AT393079B AT393079B (de) 1991-08-12

Family

ID=3492201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT49889A AT393079B (de) 1988-11-25 1989-03-06 Pharmazeutische verwendung von agmatin

Country Status (1)

Country Link
AT (1) AT393079B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1014959B1 (de) * 1997-08-15 2004-10-20 Carolyn Ann Fairbanks Agmatin für die behandlung neuropathischer schmerzen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1153424A (en) * 1965-04-15 1969-05-29 Horlicks Ltd Pharmaceutical Compositions
FR4807M (de) * 1965-09-06 1967-02-06
US4228099A (en) * 1978-03-17 1980-10-14 The Johns Hopkins University Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
IT1131854B (it) * 1980-06-30 1986-06-25 Baldacci Lab Spa Composizione farmaceutica per uso terapeutico,per uso diagnostico e quale integratore alimentare
US4758583A (en) * 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging

Also Published As

Publication number Publication date
AT393079B (de) 1991-08-12

Similar Documents

Publication Publication Date Title
ATA98488A (de) Pharmazeutische verwendung von 17-ketosteroiden
DK229489D0 (da) Laegemiddeladsorbater
NO179394C (no) Blod-prövetakingssett
BR8901828A (pt) Seringa
DE10199066I1 (de) Pharmazeutische Zusammensetzung
FI891385A7 (fi) Ruisku
IS1506B (is) Nýjar sprautur
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DK376589A (da) Engangssproejte
BR8900714A (pt) Agrafadora cirurgica
DK548689A (da) Farmaceutisk oploesning
KR900701341A (ko) 일회용 주사기
DK275490D0 (da) Kanyle
ATA133288A (de) Pharmazeutische zusammensetzung
ATA49889A (de) Pharmazeutische verwendung von agmatin
FI900941A7 (fi) Atsasyklo-oktadiiniyhdiste ja sen farmaseuttinen käyttö
ATA254988A (de) Einwegspritze
ATA263987A (de) Pharmazeutische verwendung von phenoxypentyloxy-3,4-dihydro-2h-1-benzopyrander vaten
ATA264387A (de) Pharmazeutische verwendung von phenoxypentyloxy-3,4-dihydro-2h-1-benzopyranderivaten
ATA295889A (de) Pharmazeutische verwendung eines oxipurinolsalzes
ATA246089A (de) Pharmazeutische zusammensetzung enthaltend phenylcarbamate
ATA244088A (de) Einwegspritze
BR6800483U (pt) Espetaculo descartavel
DK636688D0 (da) Medicinsk elektrode
KR910004024U (ko) 채혈용 주사기

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
ELJ Ceased due to non-payment of the annual fee